There are provided according to the invention compounds of formula (I) as CRTh2 antagonists. In free or salt form, wherein R.sup.3, R.sup.4, R.sup.5, R.sup.6, Q, W and n are as described in the specification, process for preparing them, and their use as pharmaceuticals. ##STR00001##

 
Web www.patentalert.com

< Novel Potassium Channel Blockers

> Novel Potassium Channel Blockers

> New Potassium Channel Blockers

~ 00596